Last month, Blackrock NeuroMed was very pleased to be a partner and supporter of the revealing of the new USC Neurorestoration Center.
During the one day symposium, leading physicians and researchers from around the world presented their work – along with ambitious plans and goals for the future.
The new Neurorestoration Center has positioned USC, Ranchos Los Amigos and their collaborative facilities to be leaders in the development and implementation of the latest patient care techniques offered by today’s ever expanding field of neurotechnology.
More can be read about the USC Neurorestoration Center here:USC Neurorestoration Center
Blackrock NeuroMed will demonstrate its portfolio of revolutionary Cervello EEG / LTM technology during the annual American Academy of Neurology (AAN) Meeting held in Philadelphia, PA from April 28-May 1, 2014
“Central to our company’s mission is unraveling the mystery of what causes different neurological disorders,” said Andrew Gotshalk, CEO Blackrock NeuroMed. “We look forward to attending this year’s AAN Conference so our team can demonstrate the potential of this highly-advanced technology that we believe will revolutionize diagnosis and therapy of epilepsy.”
The Cervello EEG/LTM Systems combing a full range of research and clinical capabilities. The Cervello Systems are ideally suited for LTM in Epilepsy, Invasive and Stereo-EEG recording. System features include up to 256 channels, marco- and micro-electrode recording, high sampling rates, remote monitoring capabilities, Bluetooth wireless connectivity and full HD video recording.
Tom Keener, VP of Sales and Damon Gee, Regional Sales Manager will be at the NeuroMed Booth #302 providing real-time demonstrations April 28-May 1.
The debilitating disease of epilepsy, as well as its diagnosis and treatment, presents a variety of challenges for today’s clinicians. While the oft-used techniques and methods have been around for nearly a century (surface EEG monitoring), newer technologies have become available to many of the higher-tier epilepsy centers.
As the technology advances, epilepsy treatments and research are becoming more cross-disciplinary. Neurologists who specialize in epilepsy, and who often provide the first level of diagnosis and treatment, are working more closely with neurosurgeons and neuroscientists to implement novel treatments previously not available.
The unique nature of the path often taken in severe instances of drug-resistant epilepsies offers this cross-disciplinary team remarkable access to the human brain; however, with this access comes new challenges. Each member of the clinical and research team wants or needs different tools to treat the patient, and often this requires multiple hardware and software systems.
Until recently, most epileptologists would require that the patient be monitored using surface EEG using a certain piece of recording equipment and analysis software. The neurosurgeon who is tasked with positioning subdural micro and macro electrodes would require a second piece of live monitoring hardware and software, and still a third piece of equipment would be required for the researching neuroscientist in the group.
As Blackrock NeuroMed has gained experience with each of the aforementioned groups, as well as the limitations of other types of equipment, we developed a single system with enough flexibility and sophistication to meet the needs for all. The one system, the CervelloTM Elite, provides the only complete package available in the market today. Sampling rates of up to 30 kHz across all 256 channels, a variety of digital & analog inputs/outputs, 1080p HD video and remote monitoring capabilities make the Cervello Elite an all-in-one package, which all of the groups involved in the care and treatment of the patient can focus.
The Cervello Elite System is becoming the central hub of leading epilepsy care and treatment facilities around the world. View details on the Cervello Elite page or contact one of our sales representatives for additional information.
Today as I waited for my next flight at DFW airport, I received a call from a physician who I’ve never before met in person. Though we were introduced a few months back via email, we’ve never physically met, nor spoken on the phone.
(Rather than making you, the reader, suffer through a litany of ambiguous pronouns, for the sake of this post, let us refer to her as Dr. Jane.)
Dr. Jane is not yet a user of Blackrock Neuromed’s EEG monitoring equipment, but she has learned enough about what we are working to provide the industry that she felt confident that a quick phone call could resolve an issue that she is having with her current vendor.
When I answered the phone Dr. Jane was immediately apologetic. She apologized for taking my time to ask a question about a situation involving a different vendor. After a quick reassurance that I was happy to help however I was able, she proceeded to say, “You guys are the only ones who I can ever get in touch with, and I know you’ll always have a straight forward answer for me.”
Prior to calling me Dr. Jane had made a simple request for a software feature that would make her group’s work much more efficient. Rather than working with Dr. Jane (a long time user of the vendor’s equipment) to understand why the feature is important to her work, she was told that adding any features to the existing software was not possible because development on that product had been locked.
Fortunately, the feature in question is already available in Blackrock Neuromed’s Cervello software, and once additional funding comes through for her facility, Dr. Jane hopes to become a user.
However, that feature is not really what this post is about. The situation illustrates another, often nebulous, point of consideration when deciding on a vendor with which to align your facility for the long term.
How available is the company’s representative? How willing is the company to take user feedback and how is it actually used to focus or shape product and service planning?
A company’s R&D practices are extremely telling in what the goals of the organization are. Sure, all companies need to be profitable to sustain themselves, but that cannot be the only goal. A commitment to indirectly serving the patient population in need through direct service of the medical community must be maintained at all costs.
A declined software feature request here and there may seem insignificant in the grand scheme of things, but perhaps it represents only the tip of iceberg when one considers what is truly at stake.